The effects of suramin on human adrenocortical cells in vitro: Suramin inhibits cortisol secretion and adrenocortical cell growth
- 31 October 1991
- journal article
- Published by Elsevier in Metabolism
- Vol. 40 (10) , 1020-1024
- https://doi.org/10.1016/0026-0495(91)90123-e
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Suramin for prostatic cancer: A phase I/II study in advanced extensively pretreated diseaseEuropean Journal of Cancer and Clinical Oncology, 1990
- Clinical Features of Adrenocortical Carcinoma, Prognostic Factors, and the Effect of Mitotane TherapyNew England Journal of Medicine, 1990
- Suramin inhibits proliferation of rat glioma cells and alters N-cam cell surface expressionInternational Journal of Cancer, 1990
- Suramin, an anti‐cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2AFEBS Letters, 1989
- EFFECT OF SURAMIN IN A PATIENT WITH ADRENOCORTICAL CARCINOMAThe Lancet, 1989
- Behandlung des metastasierten Nebennierenkarzinoms mit SuraminDeutsche Medizinische Wochenschrift (1946), 1989
- Suramin Antiviral Therapy in the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1986
- Suramin Protection of T Cells in Vitro Against Infectivity and Cytopathic Effect of HTLV-IIIScience, 1984
- SUPPRESSION OF LUTEINIZING HORMONE INDUCED BY ADRENOCORTICOTROPHIN IN HEALTHY WOMENJournal of Endocrinology, 1981
- Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor virusesCancer Letters, 1979